Cell and Gene Commercialization

  1. Strategic Considerations For Success In Gene-Based Therapeutics Development 8/27/2024

    The forces that impact gene therapy development continue to evolve dramatically. This paper explores strategic considerations for regulatory, operational, and commercial success.

  2. CRISPR And The Commercialization Of Gene-Based Therapies 8/27/2024

    The importance of early collaboration between drug developers, manufacturers, and payers is becoming more evident, as it aids in the creation of meaningful clinical endpoints and the formulation of a viable market access strategy.

  3. Takeaways From Cencora's Inaugural Cell And Gene Therapy Summit 8/14/2024

    Collaboration, communication, and competition are key to advancing cell and gene therapy. Experts share insights from Cencora's inaugural CGT summit.

  4. Digital Transformation In Life Sciences: The Importance Of Data Strategy 8/8/2024

    Learn how to align data with business objectives, ensure clean and contextualized data, and establish comprehensive data standards and governance with a robust data strategy.

  5. Bringing A Device From Concept To Market 8/2/2024

    Within three years, see how this company was able to achieve FDA approval and CE Marking, facilitating its entry into the U.S. and EU markets.

  6. Identifying Drug Development Opportunities For DMD With CureDuchenne 8/1/2024

    Debra Miller, CEO and Founder and Dr. Michael Kelly, Chief Scientific Officer at CureDuchenne talk to Host Erin Harris about the FDA approval for the expansion to the label indication for ELEVIDYS from Sarepta Therapeutics as well as how CureDuchenne works with various biotechs developing gene therapies for Duchenne muscular dystrophy (DMD).

  7. CGT Expert Consulting Team 7/24/2024

    At ProPharma, our Cell and Gene Therapy consulting team offers a comprehensive and integrated approach to early-stage cell and gene therapy development. Our expert team provides a range of services, including IND/CTA preparation, manufacturing technology, safety and risk assessment, and development planning, to help our clients navigate the complex and ever-changing landscape of cell and gene therapy development.

  8. Navigating The Challenges Of Bringing Cell And Gene Therapies To Market 7/24/2024

    Cell and gene therapies are witnessing rapid advancements, but significant challenges remain for their commercialization due to regulatory hurdles, manufacturing barriers, high costs, and safety concerns.

  9. Help Bring Your Breakthrough Cancer Treatments To Market Faster 7/18/2024

    Let us expedite the journey of your treatment from the research phase to the patient, ensuring that life-saving therapies reach those in need as swiftly as possible.

  10. Wherever You're Going, Our Regulatory And Access Experts Have Been There 7/18/2024

    With our consulting team by your side, comprised of over 1,000 dedicated professionals, you can be confident that your treatment’s journey from research to patient care is in expert hands.